A national surveillance approach to monitor incidence of eclampsia: The Netherlands Obstetric Surveillance System

Timme P. Schaap, Thomas van den Akker, Joost J. Zwart, Jos van Roosmalen, Kitty W.M. Bloemenkamp

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

Introduction: There have been many efforts in the last decade to decrease the incidence of eclampsia and its related complications in the Netherlands, such as lowering thresholds for treatment of hypertension and mandatory professional training. To determine the impact of these policy changes on incidence and outcomes, we performed a nationwide registration of eclampsia, 10 years after the previous registration. Material and methods: Cases of eclampsia were prospectively collected using the Netherlands Obstetric Surveillance System (NethOSS; 2013-2016) in all hospitals with a maternity unit in the Netherlands. Complete case file copies were obtained for comparative analysis of individual level data with the previous cohort (2004-2006). Primary outcome measure was incidence of eclampsia; main secondary outcomes were antihypertensive and magnesium sulfate use, and maternal and perinatal mortality. Results: NethOSS identified 88 women with eclampsia. The incidence decreased from 6.2/10 000 in 2004-2006 to 1.8/10 000 births (relative risk [RR] 0.28, 95% confidence interval [CI] 0.22-0.36). Increases in the use of antihypertensive medication (61/82 vs 35/216; RR 18.4, 95% CI 9.74-34.70) and magnesium sulfate treatment (82/82 vs 201/216; RR 1.08, 95% CI 1.04-1.12) were observed. There was one intrauterine death following termination of pregnancy. No cases of neonatal mortality were reported in NethOSS compared with 11 in the LEMMoN. Maternal death occurred in one woman compared vs three in the previous registration. Conclusions: There has been a strong reduction of eclampsia and associated perinatal mortality in the Netherlands over the last decade. Management changes and increased awareness may have contributed to this reduction.

Original languageEnglish
Pages (from-to)342-350
Number of pages9
JournalActa Obstetricia et Gynecologica Scandinavica
Volume98
Issue number3
Early online date22 Oct 2018
DOIs
Publication statusPublished - Mar 2019

Fingerprint

Eclampsia
Netherlands
Obstetrics
Incidence
Magnesium Sulfate
Perinatal Mortality
Confidence Intervals
Antihypertensive Agents
Maternal Death
Maternal Mortality
Infant Mortality
Outcome Assessment (Health Care)
Parturition
Hypertension
Pregnancy
Therapeutics

Keywords

  • eclampsia
  • INOSS
  • maternal morbidity
  • NethOSS
  • obstetric surveillance system

Cite this

Schaap, Timme P. ; van den Akker, Thomas ; Zwart, Joost J. ; van Roosmalen, Jos ; Bloemenkamp, Kitty W.M. / A national surveillance approach to monitor incidence of eclampsia : The Netherlands Obstetric Surveillance System. In: Acta Obstetricia et Gynecologica Scandinavica. 2019 ; Vol. 98, No. 3. pp. 342-350.
@article{a5756b4dbd184a4887138e617625d28e,
title = "A national surveillance approach to monitor incidence of eclampsia: The Netherlands Obstetric Surveillance System",
abstract = "Introduction: There have been many efforts in the last decade to decrease the incidence of eclampsia and its related complications in the Netherlands, such as lowering thresholds for treatment of hypertension and mandatory professional training. To determine the impact of these policy changes on incidence and outcomes, we performed a nationwide registration of eclampsia, 10 years after the previous registration. Material and methods: Cases of eclampsia were prospectively collected using the Netherlands Obstetric Surveillance System (NethOSS; 2013-2016) in all hospitals with a maternity unit in the Netherlands. Complete case file copies were obtained for comparative analysis of individual level data with the previous cohort (2004-2006). Primary outcome measure was incidence of eclampsia; main secondary outcomes were antihypertensive and magnesium sulfate use, and maternal and perinatal mortality. Results: NethOSS identified 88 women with eclampsia. The incidence decreased from 6.2/10 000 in 2004-2006 to 1.8/10 000 births (relative risk [RR] 0.28, 95{\%} confidence interval [CI] 0.22-0.36). Increases in the use of antihypertensive medication (61/82 vs 35/216; RR 18.4, 95{\%} CI 9.74-34.70) and magnesium sulfate treatment (82/82 vs 201/216; RR 1.08, 95{\%} CI 1.04-1.12) were observed. There was one intrauterine death following termination of pregnancy. No cases of neonatal mortality were reported in NethOSS compared with 11 in the LEMMoN. Maternal death occurred in one woman compared vs three in the previous registration. Conclusions: There has been a strong reduction of eclampsia and associated perinatal mortality in the Netherlands over the last decade. Management changes and increased awareness may have contributed to this reduction.",
keywords = "eclampsia, INOSS, maternal morbidity, NethOSS, obstetric surveillance system",
author = "Schaap, {Timme P.} and {van den Akker}, Thomas and Zwart, {Joost J.} and {van Roosmalen}, Jos and Bloemenkamp, {Kitty W.M.}",
year = "2019",
month = "3",
doi = "10.1111/aogs.13493",
language = "English",
volume = "98",
pages = "342--350",
journal = "Acta Obstetricia et Gynecologica Scandinavica",
issn = "0001-6349",
publisher = "Wiley-Blackwell",
number = "3",

}

A national surveillance approach to monitor incidence of eclampsia : The Netherlands Obstetric Surveillance System. / Schaap, Timme P.; van den Akker, Thomas; Zwart, Joost J.; van Roosmalen, Jos; Bloemenkamp, Kitty W.M.

In: Acta Obstetricia et Gynecologica Scandinavica, Vol. 98, No. 3, 03.2019, p. 342-350.

Research output: Contribution to JournalArticleAcademicpeer-review

TY - JOUR

T1 - A national surveillance approach to monitor incidence of eclampsia

T2 - The Netherlands Obstetric Surveillance System

AU - Schaap, Timme P.

AU - van den Akker, Thomas

AU - Zwart, Joost J.

AU - van Roosmalen, Jos

AU - Bloemenkamp, Kitty W.M.

PY - 2019/3

Y1 - 2019/3

N2 - Introduction: There have been many efforts in the last decade to decrease the incidence of eclampsia and its related complications in the Netherlands, such as lowering thresholds for treatment of hypertension and mandatory professional training. To determine the impact of these policy changes on incidence and outcomes, we performed a nationwide registration of eclampsia, 10 years after the previous registration. Material and methods: Cases of eclampsia were prospectively collected using the Netherlands Obstetric Surveillance System (NethOSS; 2013-2016) in all hospitals with a maternity unit in the Netherlands. Complete case file copies were obtained for comparative analysis of individual level data with the previous cohort (2004-2006). Primary outcome measure was incidence of eclampsia; main secondary outcomes were antihypertensive and magnesium sulfate use, and maternal and perinatal mortality. Results: NethOSS identified 88 women with eclampsia. The incidence decreased from 6.2/10 000 in 2004-2006 to 1.8/10 000 births (relative risk [RR] 0.28, 95% confidence interval [CI] 0.22-0.36). Increases in the use of antihypertensive medication (61/82 vs 35/216; RR 18.4, 95% CI 9.74-34.70) and magnesium sulfate treatment (82/82 vs 201/216; RR 1.08, 95% CI 1.04-1.12) were observed. There was one intrauterine death following termination of pregnancy. No cases of neonatal mortality were reported in NethOSS compared with 11 in the LEMMoN. Maternal death occurred in one woman compared vs three in the previous registration. Conclusions: There has been a strong reduction of eclampsia and associated perinatal mortality in the Netherlands over the last decade. Management changes and increased awareness may have contributed to this reduction.

AB - Introduction: There have been many efforts in the last decade to decrease the incidence of eclampsia and its related complications in the Netherlands, such as lowering thresholds for treatment of hypertension and mandatory professional training. To determine the impact of these policy changes on incidence and outcomes, we performed a nationwide registration of eclampsia, 10 years after the previous registration. Material and methods: Cases of eclampsia were prospectively collected using the Netherlands Obstetric Surveillance System (NethOSS; 2013-2016) in all hospitals with a maternity unit in the Netherlands. Complete case file copies were obtained for comparative analysis of individual level data with the previous cohort (2004-2006). Primary outcome measure was incidence of eclampsia; main secondary outcomes were antihypertensive and magnesium sulfate use, and maternal and perinatal mortality. Results: NethOSS identified 88 women with eclampsia. The incidence decreased from 6.2/10 000 in 2004-2006 to 1.8/10 000 births (relative risk [RR] 0.28, 95% confidence interval [CI] 0.22-0.36). Increases in the use of antihypertensive medication (61/82 vs 35/216; RR 18.4, 95% CI 9.74-34.70) and magnesium sulfate treatment (82/82 vs 201/216; RR 1.08, 95% CI 1.04-1.12) were observed. There was one intrauterine death following termination of pregnancy. No cases of neonatal mortality were reported in NethOSS compared with 11 in the LEMMoN. Maternal death occurred in one woman compared vs three in the previous registration. Conclusions: There has been a strong reduction of eclampsia and associated perinatal mortality in the Netherlands over the last decade. Management changes and increased awareness may have contributed to this reduction.

KW - eclampsia

KW - INOSS

KW - maternal morbidity

KW - NethOSS

KW - obstetric surveillance system

UR - http://www.scopus.com/inward/record.url?scp=85058050397&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058050397&partnerID=8YFLogxK

U2 - 10.1111/aogs.13493

DO - 10.1111/aogs.13493

M3 - Article

VL - 98

SP - 342

EP - 350

JO - Acta Obstetricia et Gynecologica Scandinavica

JF - Acta Obstetricia et Gynecologica Scandinavica

SN - 0001-6349

IS - 3

ER -